March 6, 2019

Craig Ellins
Chief Executive Officer
One World Pharma, Inc.
3471 West Oquendo Road, Suite 301
Las Vegas, NV 89118

       Re: One World Pharma, Inc.
           Current Report on Form 8-K
           Filed February 25, 2019
           File No. 333-200529

Dear Mr. Ellins:

        Our preliminary review of your Form 8-K filed February 25, 2019
indicates that it fails in
material respects to comply with the requirements of the Securities Exchange
Act of 1934, the
rules and regulations under that Act, and the requirements of the Form. In
particular, please
provide updated audited financial statements as of and for the fiscal year
ended December 31,
2018 in accordance with Article 8-08 of Regulation S-X, as well as updated pro
forma financial
information in accordance with Article 8-05 of Regulation S-X. Until you
provide this
information, we will not perform a detailed examination of your filing, and we
will not issue
comments.

      Please promptly amend the current report to correct the deficiency noted
above. You
may contact Mary Beth Breslin, Legal Branch Chief, at (202) 551-3625 with any
questions.



                                                            Sincerely,

                                                            Division of
Corporation Finance
                                                            Office of
Healthcare & Insurance
cc:    Zev M. Bomrind